pharmaceuticals — Lanton Law Blog

Pharmaceutical Commerce Speaks with Lanton Law about New Drug Pricing Models

Pharmaceutical Commerce interviews Ron Lanton; Partner at Lanton Law on newly emerging pricing models such as the cost plus drug model.

healthcare, legislation, life sciences, Congress, FTCRon LantonJanuary 31, 2024healthcare, drug price, Mark Cuban Cost Plus Drug Company, cost plus pricing model, Pharmacy Benefit Manager, insurance, pharmaceuticals, pharmacy, PhRMA

Biden Administration Announces First Ten Drugs Selected for Medicare Price Negotiation

The Biden Administration has announced today that Medicare will be able to negotiate drug prices for the first time due to provisions within the Inflation Reduction Act.

healthcare, life sciences, Medicare Part D, pharmaceuticals, prescription drug costsRon LantonAugust 29, 2023Inflation Reduction Act, drug prices, pharmaceuticals, prescription drug prices, Medicare Part D, CMS, HHS

White House Releases Report Outlining Steps to Strengthen Critical Supply Chains

In February 2021, President Biden issued an Executive Order to direct a government-wide “approach to assessing vulnerabilities in, and strengthening the resilience of, critical supply chains.”